Group 1: Core Insights - The company is advancing its share repurchase plan and intends to issue short-term financing bonds to supplement working capital [1][3] Group 2: Stock Performance - As of January 31, 2026, the company has repurchased a total of 13,047,066 shares, representing 1.17% of its total share capital, with a total repurchase amount of approximately 135 million yuan [2] Group 3: Funding Movements - The company plans to issue short-term financing bonds not exceeding 2 billion yuan to supplement working capital and repay loans, with the proposal already approved by the board and the first temporary shareholders' meeting of 2026, pending regulatory approval [3]

Group 1: Company Announcements - ST Lianchuang announced a share buyback plan through centralized bidding, with a maximum repurchase price of 3.26 yuan per share, funded by its own resources [1] - The company adjusted the repurchase price of restricted stock to 3.2598 yuan per share due to the departure of incentive targets and canceled 594,240 shares, reducing the total share capital to 1,068,374,880 shares, with no substantial impact on financial status [1] - The set maximum buyback price is 48.17% lower than the current stock price, indicating the company's cautious attitude towards its valuation level [1] Group 2: Stock Performance - Over the past 7 days (February 7 to 13, 2026), ST Lianchuang's stock price showed volatility, with a single-day increase of 2.41% on February 11, followed by declines of 1.26% and 0.16% on February 12 and 13, respectively [2] - As of February 13, the stock closed at 6.28 yuan, with a year-to-date increase of 4.15%, slightly below the market's performance (Shanghai Composite Index rose 0.41% in the same period) [2] - On February 9, there was a net inflow of 14.0791 million yuan in main funds, but on February 13, it turned into a net outflow of 3.5460 million yuan, indicating short-term fluctuations in fund sentiment [2] Group 3: Financial Performance - According to the Q3 2025 report, the company achieved a revenue of 690 million yuan in the first three quarters, a year-on-year increase of 4.48%, and a net profit attributable to shareholders of 16.4648 million yuan, a significant year-on-year increase of 198.11%, mainly due to improved gross margins in fluorine-containing new materials and optimized operational efficiency [3] - However, the revenue for the third quarter alone declined by 7.75% year-on-year, raising concerns about the sustainability of performance growth [3] - The company's financial structure shows a debt-to-asset ratio of 19.84%, with both current and quick ratios at healthy levels, indicating low short-term repayment risk [3]

Group 1 - The company plans to repurchase shares using its own funds, with an amount between 150 million to 200 million yuan, aimed at employee incentives and enhancing investor confidence [1] - The first repurchase was executed on February 11, 2026, with 77,000 shares bought back at a total cost of approximately 18.61 million yuan [1] - The recent opening of the national drug procurement may have indirect effects on the medical device industry, although the company's core business focuses on electrophysiology and interventional devices [1] Group 2 - Huayuan Securities initiated coverage on the company on February 13, 2026, giving it a "buy" rating, with expected compound annual growth rates for revenue and net profit exceeding 24% from 2025 to 2027 [2] - In the past 90 days, four institutions have rated the company, with three giving a "buy" and one an "overweight" rating, indicating positive expectations from analysts [2]

康臣药业此前公告，于2025年6月13日，董事局决议执行股份回购计划，以资金总数不超过2亿港元为 限，于公开市场适时回购股份(先前股份回购计划)。于2026年1月29日，董事局决议根据购回授权进一 步执行另一项股份回购计划，以于公开市场适时回购股份，除先前股份回购计划的资金总数外，额外增 加最多1亿港元(股份回购计划)。据此股份回购计划合计拟动用资金总额将不超过3亿港元。股份回购计 划之期限自本公告日期起至公司下届股东周年大会结束时止或股东于股东大会上撤回或修订购回授权为 止。 2月13日，恒生指数公司宣布截至2025年12月31日之恒生指数系列季度检讨结果，其中康臣药业(01681) 获纳入恒生综合指数。变动将于2026年3月6日(星期五)收市后实施并于2026年3月9日(星期一)起生效， 届时沪深交易所会相应调整港股通可投资标的范围。据中金研报，康臣药业有可能被调入港股通，因其 满足了包括市值、流动性和上市时间等在内的一系列标准。 ...

行业政策与环境 近期，人社部等七部门对包括快递企业在内的平台企业开展用工行政指导，强调保障新就业形态劳动者 权益。此类政策有助于引导行业从"价格竞争"转向"质量竞争"，改善整体盈利预期，利好中通等龙头企 业。 经济观察网 根据公开信息，中通快递-W（02057.HK）股价在近期（截至2026年2月11日）创出阶段性 新高，主要受以下几方面因素推动： 股价与资金表现 公司于2026年2月4日斥资约32.69亿港元回购1825.44万股，并于2月10日及11日连续在美国市场回购美国 存托股份（ADR）。持续的股份回购向市场传递了管理层对公司内在价值的认可，对股价形成直接支 撑。 2026年2月11日，港股航空物流板块整体上涨，恒生指数收涨，市场情绪偏暖对个股形成带动。南向资 金在近期也呈现净流入态势，反映资金对港股快递板块的关注度提升。 以上内容基于公开资料整理，不构成投资建议。 公司基本面 根据机构分析，中通快递在2025年第三季度业务量保持增长，散件业务表现强劲，"反内卷"趋势带动单 票盈利环比改善。公司2025年全年业绩预估显示，收入预计达485-500亿元，同比增长9.5%-12.9%；包 裹量385.2 ...

Group 1 - BOSS Zhipin has conducted multiple share buybacks to implement an employee incentive plan, purchasing a total of 343,300 Class A common shares on February 12, 2026, and 335,900 shares on February 6, 2026, funded by internal resources [1] - As of February 13, 2026, BOSS Zhipin's stock price was $17.37, reflecting a 1.42% decline on that day and a cumulative drop of 3.07% over the past five days, with a total market capitalization of approximately $8.08 billion and a TTM price-to-earnings ratio of 22.65 [1] Group 2 - In February 2026, BOSS Zhipin initiated a special governance action against "recruitment fraud," resulting in the banning of 1,502 risky enterprises and freezing over 2,000 related accounts weekly, utilizing AI semantic recognition and manual review systems to enhance platform integrity and trust among job seekers [2] - On February 11, 2026, Collette Technology received the "Most Loved Talent Employer" award at BOSS Zhipin's annual partner conference, based on real user behavior data from 2025, reflecting the platform's active ecosystem and corporate recognition [2]

股票近期走势近7天(2026年2月5日至2月12日)，爱立信股价呈现波动态势。根据内部数据库，截至2月 12日收盘，股价为10.97美元，单日跌幅1.53%，但5日涨跌幅为0.27%，年初至今累计上涨13.68%3,4。 区间振幅达5.02%，成交活跃，显示市场关注度较高。市盈率(TTM)为11.87，市净率为2.973,4。 以上内容基于公开资料整理，不构成投资建议。 经济观察网爱立信于2026年2月12日发布2025年第四季度及全年财报，宣布启动额度为150亿瑞典克朗 (约17亿美元)的股份回购计划，预计在2026年第一季度财报发布后实施，并持续至2027年4。董事会提 议将2025年度股息从每股2.85瑞典克朗提高至每股3.00瑞典克朗，该议案将提交年度股东大会审议4。公 司预计无线接入网(RAN)市场表现平淡，但任务关键型网络和企业级业务有望增长，并计划在2026年增 加防御领域投资，优化成本结构以支撑利润率4。这些财务决策可能对投资者情绪产生积极影响。 近期事件2026年2月4日，爱立信获得香港运营商数码通(SmarTone)的5G-Advanced设备订单，将提供5G 核心网平台及新一代无线设备， ...

公司状况 乐信在2025年三季度披露，6000万美元股份回购计划已执行过半，且下半年分红比例由25%提升至 30%。这些举措的后续执行情况可能影响股东回报。 根据gu.qq.com在2026年2月的报道，乐信等头部金融科技公司因应对2025年落地的新规，已主动剥离超 高利率客户，这一举措对短期经营利润的向下影响预计将体现在2025年四季报中。财报发布后，市场可 关注其资产质量、利润表现及新规适应情况。 经济观察网 基于最新公开信息，乐信（NASDAQ: LX）在2026年年初有以下事件值得关注： 业绩经营情况 ...

Investment Rating - The report indicates a positive investment outlook for Kajima Corporation, reflecting the potential opportunities in Japan's data center construction boom [5]. Core Insights - Kajima Corporation's stock price is seen as already reflecting the potential opportunities from the surge in data center construction in Japan. The company is expected to capture about 50% of the nuclear power construction market, giving it an advantage in securing high-profit data center projects [5]. - The company has raised its full-year operating profit guidance from 202 billion yen to 228 billion yen, primarily due to additional payments from clients [6]. - The gross profit margin for the construction business reached 11.8%, an increase of 2.4 percentage points year-on-year, while the civil engineering gross profit margin rose to 24.6%, up 10.2 percentage points year-on-year [7]. Financial Performance - For the first three quarters, Kajima Corporation reported an operating profit of 171.8 billion yen, leading to an upward revision of its full-year operating profit guidance [6]. - The company aims to reduce its cross-shareholding ratio from 22.3% to below 20% by the end of the fiscal year ending March 2027, planning to dispose of a total of 50 billion yen in cross-shareholdings [8]. Market Position - Kajima Corporation is one of Japan's four major general construction companies, with a significant focus on private sector construction projects, which is expected to continue [11]. - The company's overseas real estate business, primarily focused on U.S. logistics development, has become another pillar of its operations [11]. Revenue Breakdown - Revenue by product: Construction engineering (41.4%), Overseas affiliates (32.2%), Civil engineering (13.6%), Domestic affiliates (9.7%) [12]. - Revenue by region: Asia (79.6%), Europe (1.7%), Middle East and Africa (0.1%), Americas (18.7%) [12]. Stock Information - As of February 12, 2026, the stock price was 7,612.0 yen, with a market capitalization of 26.55 billion USD [14].

（编辑 楚丽君） 证券日报网讯 2月13日，万泰生物在互动平台回答投资者提问时表示，上市公司实施股份回购是一项审 慎的重大决策，需要综合考虑市场环境、股价走势、公司财务状况、资金安排、后续用途以及债权人的 合法权益等多方面因素，公司将严格按照《上海证券交易所股票上市规则》及《上市公司股份回购规 则》等法律法规的要求，履行审议程序及信息披露义务。 ...